mumps clinical trials

A Phase II, single-blind, randomized, controlled study to evaluate the immunogenicity and safety of a measles, mumps, rubella, varicella vaccine compared with ProQuad, administered in healthy children 4 to 6 years of age

This study looks at a new vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. Researchers want to see how well it works compared to an existing vaccine and if it's safe. It's an important step in making sure vaccines protect our children.